Ask the Expert: Lymphedema

December 11, 2018
07:00pm to 07:30pm
2018-12-11 19:00:00 2018-12-11 19:30:00 America/New_York Ask the Expert: Lymphedema  


Anyone who has had lymph node surgery as part of breast cancer treatment is at risk for lymphedema, a condition where fluid builds up in your hand, arm or chest wall and causes swelling. But lymphedema often isn’t discussed or well understood. Whether you’re living with lymphedema or want to learn how reduce your risks of getting it, you may have questions about the condition.

Janine Guglielmino, Living Beyond Breast Cancer’s senior director of programs and partnerships, will discuss lymphedema with Wilma Morgan-Hazelwood, OT, CLT, LANA and Josh Levin of LympheDIVAs and answer your questions, live. 

Remember: we cannot provide diagnoses, medical consultations or specific treatment recommendations. This service is designed for educational and informational purposes only. The information is general in nature. For specific healthcare questions or concerns, consult your healthcare provider because treatment varies with individual circumstances. The content is not intended in any way to substitute for professional counseling or medical advice. 


Moderated by:

Janine E. Guglielmino, MA 
Janine oversees the implementation of our programs, publications and research initiatives. In this role, she contributes to the content and design of all core LBBC activities. She leads needs assessments and evaluative activities that ensure the high quality of existing and future programming. Read more.

Josh Levin
Josh Levin became president of LympheDIVAs in 2010, 3 years after his sister passed away from breast cancer. Before joining LympheDIVAs, Josh had several different careers. Read more.
Wilma Morgan-Hazelwood, OT, CLT, LANA
Wilma Morgan-Hazelwood, OT, CLT, LANA, is a nationally recognized lymphedema expert with over 40 years of clinical experience as an occupational therapist. She is the manager of the lymphedema department at Holy Redeemer in Southampton, Pennsylvania. Read more.